EVEROLIMUS, EVEROLIMUS, PF-07248144, FULVESTRANT, EVEROLIMUS, EXEMESTANE, FULVESTRANT, PF-07248144
C4551002
Phase 3 small_molecule active
Quick answer
EVEROLIMUS, EVEROLIMUS, PF-07248144, FULVESTRANT, EVEROLIMUS, EXEMESTANE, FULVESTRANT, PF-07248144 for Hormone Receptor-Positive, HER2-Negative Advanced/Metastatic Breast Cancer is a Phase 3 program (small_molecule) at Pfizer Ireland Pharmaceuticals Unlimited Company with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer Ireland Pharmaceuticals Unlimited Company
- Indication
- Hormone Receptor-Positive, HER2-Negative Advanced/Metastatic Breast Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active